Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - amoxicillin trihydrate 287mg equivalent to amoxycillin 250 mg;   - capsule - 250 mg - active: amoxicillin trihydrate 287mg equivalent to amoxycillin 250 mg   excipient: gelatin magnesium stearate microcrystalline cellulose - ospamox is indicated in the treatment of infections due to susceptible organisms. ospamox may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to amoxicillin should be performed. ospamox may be used for the prevention of bacteraemia, associated with procedures such as dental extraction, in patients at risk of developing bacterial endocarditis.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - amoxicillin trihydrate 574mg equivalent to amoxycillin 500 mg;   - capsule - 500 mg - active: amoxicillin trihydrate 574mg equivalent to amoxycillin 500 mg   excipient: gelatin magnesium stearate microcrystalline cellulose - ospamox is indicated in the treatment of infections due to susceptible organisms. ospamox may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to amoxicillin should be performed. ospamox may be used for the prevention of bacteraemia, associated with procedures such as dental extraction, in patients at risk of developing bacterial endocarditis.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate (equivalent: amoxicillin, qty mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; iron oxide yellow; titanium dioxide; gelatin - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. respiratory tract infections (acute and chronic): h, influenzae; streptococcus; s. pneumoniae; staphylococcus, non-pencillinase producing; e. coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic): e, coli (see microbiology); p. mirabilis; s. faecalis. gonorrhoea (n.gonorrhoeae, non-penicillinase producing). skin and skin structure infections: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see microbiology). prophylaxis of endocarditis. amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. infections caused by pathogens with established penicillin g susceptibility should preferentially be treated with penicillin g.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate (equivalent: amoxicillin, qty mg) - capsule, hard - excipient ingredients: magnesium stearate; microcrystalline cellulose; iron oxide yellow; titanium dioxide; gelatin - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin, alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. respiratory tract infections: (acute and chronic): h.influenzae; streptococcus; s.pneumoniae; staphylococcus, non-penicillinase producing; e.coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic) e.coli (see microbiology); p.mirabilis; s.faecalis. gonorrhoea (n.gonorrhoeae, non-penicillinase producing). skin and skin structure infections: staaphylococcus, non-penicillinase producing: streptococcus: e.coli (see microbiology). prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. infections caused by pathgogens with established pencicillin g susceptibility should be preferentially treated with penicillin g.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amoxicillin trihydrate -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amoxicillin trihydrate, quantity: 574 mg (equivalent: amoxicillin, qty 500 mg); potassium clavulanate, quantity: 149 mg (equivalent: amoxicillin, qty 500 mg; equivalent: clavulanic acid, qty 125 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; purified talc; povidone; triethyl citrate; hypromellose; titanium dioxide; ethylcellulose - short-term treatment of bacterial infection at the following sites when caused by amoxycillin/clavulanic acid sensitive, beta-lactamase producing organisms. skin and skin structure infections. urinary tract infections (uncomplicated and complicated). upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis. lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis. appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxycillin/clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in the microbiological section, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused

Australia - englanti - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 57.8 mg/ml (equivalent: amoxicillin, qty 50 mg/ml) - suspension, powder for - excipient ingredients: sorbitol; colloidal anhydrous silica; sunset yellow fcf; sodium citrate dihydrate; xanthan gum; saccharin sodium; flavour - indications: treatment of the following infections due to susceptible strains of sensitive organisms. note. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see microbiology). respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, nonpenicillinase producing; e. coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e. coli (see microbiology), p. mirabilis and strep. faecalis. gonorrhoea: n. gonorrhoeae (nonpenicillinase producing). prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - amoxicillin trihydrate 574mg equivalent to amoxycillin 500 mg;  ; potassium clavulanate 149mg equivalent to clavulanic acid 125 mg;   - film coated tablet - 500mg/125mg - active: amoxicillin trihydrate 574mg equivalent to amoxycillin 500 mg   potassium clavulanate 149mg equivalent to clavulanic acid 125 mg   excipient: croscarmellose sodium ethylcellulose hypromellose magnesium stearate microcrystalline cellulose povidone purified talc   purified water titanium dioxide triethyl citrate - short term treatment of common bacterial infections such as: upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections skin and soft tissue infections bone and joint infections: e.g. osteomyelitis other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis and post-surgical infections. prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery. infections caused by amoxycillin susceptible organisms are amenable to amoxycillin/clavulanic acid treatment due to its amoxycillin content. mixed infections caused by amoxycillin susceptible organisms in conjunction with amoxycillin/clavulanic acid susceptible beta-lactamase-producing organisms may therefore be treated by amoxycillin/clavulanic acid.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 573.9 mg (equivalent: amoxicillin, qty 500 mg) - capsule, hard - excipient ingredients: iron oxide yellow; erythrosine; titanium dioxide; indigo carmine; magnesium stearate; gelatin; purified talc; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia; potassium hydroxide - indications as at 14th february 2005: it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note; therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli (see microbiology). respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbiology), p.mirabilis and s.faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxil may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 286.95 mg (equivalent: amoxicillin, qty 250 mg) - capsule, hard - excipient ingredients: erythrosine; iron oxide yellow; titanium dioxide; magnesium stearate; gelatin; indigo carmine; purified talc; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia; potassium hydroxide - indications as at 14th february 2005: it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note; therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli (see microbiology). respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbiology), p.mirabilis and s.faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxil may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.